ISIN | CH0461413913 |
---|---|
Valor Number | 46141391 |
Bloomberg Global ID | |
Fund Name | Swisscanto (CH) Index Equity Fund United Kingdom FA GBP |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | Die Anlagen dieses Teilvermögens erfolgen in Anlehnung an den MSCI® United Kingdom Index, welcher von der MORGAN STANLEY CAPITAL INTERNATIONAL INC. (MSCI) fest-gelegt und berechnet wird und darauf ausgelegt ist, die Performance der Mid- und Large Cap Segmente des Marktes des Vereinigten Königreiches (Grossbritannien und Nordirland) zu messen. |
Peculiarities |
Current Price * | 132.75 GBP | 26.08.2025 |
---|---|---|
Previous Price * | 133.55 GBP | 22.08.2025 |
52 Week High * | 133.55 GBP | 22.08.2025 |
52 Week Low * | 108.54 GBP | 09.04.2025 |
NAV * | 132.75 GBP | 26.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 148,612,854 | |
Unit/Share Assets *** | 5,159,814 | |
Trading Information SIX |
YTD Performance | +16.29% |
31.12.2024 - 26.08.2025
31.12.2024 26.08.2025 |
---|---|---|
YTD Performance (in CHF) | +11.02% |
31.12.2024 - 26.08.2025
31.12.2024 26.08.2025 |
1 month | +2.86% |
28.07.2025 - 26.08.2025
28.07.2025 26.08.2025 |
3 months | +6.61% |
27.05.2025 - 26.08.2025
27.05.2025 26.08.2025 |
6 months | +8.52% |
26.02.2025 - 26.08.2025
26.02.2025 26.08.2025 |
1 year | +14.41% |
27.08.2024 - 26.08.2025
27.08.2024 26.08.2025 |
2 years | +33.27% |
29.08.2023 - 26.08.2025
29.08.2023 26.08.2025 |
3 years | +37.87% |
26.08.2022 - 26.08.2025
26.08.2022 26.08.2025 |
5 years | +86.92% |
26.08.2020 - 26.08.2025
26.08.2020 26.08.2025 |
Equity Participation Rate in % | 98.11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AstraZeneca PLC | 8.29% | |
---|---|---|
HSBC Holdings PLC | 7.70% | |
Shell PLC | 7.66% | |
Unilever PLC | 5.20% | |
Rolls-Royce Holdings PLC | 4.29% | |
British American Tobacco PLC | 3.77% | |
RELX PLC | 3.43% | |
BP PLC | 3.06% | |
GSK PLC | 2.76% | |
BAE Systems PLC | 2.57% | |
Last data update | 31.07.2025 |
TER | 0.20% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.40% |
Ongoing Charges *** | 0.20% |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |